Pathogenesis of Alcoholic Fatty Liver a Narrative Review

被引:13
作者
Seitz, Helmut K. [1 ]
Moreira, Bernardo [1 ]
Neuman, Manuela G. [2 ]
机构
[1] Heidelberg Univ, Ethianum Clin, Fac Med, Ctr Liver & Alcohol Associated Dis, D-69120 Heidelberg, Germany
[2] Univ Toronto, Temer Fac Med, Dept Pharmacol & Toxicol, In Vitro Drug Safety & Biotechnol,Banting Inst, Toronto, ON M5G OA3, Canada
来源
LIFE-BASEL | 2023年 / 13卷 / 08期
关键词
alcoholic fatty liver; adenosine monophosphate activated kinase; sterol regulatory element binding protein 1c; peroxisome proliferator activated receptor alpha; oxidative stress; OXIDATIVE STRESS; INTESTINAL PERMEABILITY; CYTOCHROME P4502E1; ETHANOL-METABOLISM; GUT MICROBIOTA; KNOCKOUT MICE; DISEASE; INJURY; CYP2E1; WINE;
D O I
10.3390/life13081662
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Alcohol effect hepatic lipid metabolism through various mechanisms, leading synergistically to an accumulation of fatty acids (FA) and triglycerides. Obesity, as well as dietary fat (saturated fatty acids (FA) versus poly-unsaturated fatty acids (PUFA)) may modulate the hepatic fat. Alcohol inhibits adenosine monophosphate activated kinase (AMPK). AMPK activates peroxisome proliferator activated receptor a (PPAR alpha) and leads to a decreased activation of sterol regulatory element binding protein 1c (SRABP1c). The inhibition of AMPK, and thus of PPAR alpha, results in an inhibition of FA oxidation. This ss-oxidation is further reduced due to mitochondrial damage induced through cytochrome P4502E1 (CYP2E1)-driven oxidative stress. Furthermore, the synthesis of FAs is stimulated through an activation of SHREP1. In addition, alcohol consumption leads to a reduced production of adiponectin in adipocytes due to oxidative stress and to an increased mobilization of FAs from adipose tissue and from the gut as chylomicrons. On the other side, the secretion of FAs via very-low-density lipoproteins (VLDL) from the liver is inhibited by alcohol. Alcohol also affects signal pathways such as early growth response 1 (Egr-1) associated with the expression of tumour necrosis factor alpha (TNF alpha), and the mammalian target of rapamycin (mTOR) a key regulator of autophagy. Both have influence the pathogenesis of alcoholic fatty liver. Alcohol-induced gut dysbiosis contributes to the severity of ALD by increasing the metabolism of ethanol in the gut and promoting intestinal dysfunction. Moreover, pathogen-associated molecular patterns (PAMPS) via specific Toll-like receptor (TLR) bacterial overgrowth leads to the translocation of bacteria. Endotoxins and toxic ethanol metabolites enter the enterohepatic circulation, reaching the liver and inducing the activation of the nuclear factor kappa-B (NF kappa B) pathway. Pro-inflammatory cytokines released in the process contribute to inflammation and fibrosis. In addition, cellular apoptosis is inhibited in favour of necrosis.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different
    Malnick, Stephen D. H.
    Alin, Pavel
    Somin, Marina
    Neuman, Manuela G.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [32] Effects of Eriobotrya japonica Water Extract on Alcoholic and Nonalcoholic Fatty Liver Impairment
    Mun, Jeongeun
    Park, Jeongjin
    Yoon, Ho-Geun
    You, Yanghee
    Choi, Kyung-Chul
    Lee, Yoo-Hyun
    Kim, Kyungmi
    Lee, Jeongmin
    Kim, Ok-Kyung
    Jun, Woojin
    JOURNAL OF MEDICINAL FOOD, 2019, 22 (12) : 1262 - 1270
  • [33] Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
    Ramai, Daryl
    Facciorusso, Antonio
    Vigandt, Erika
    Schaf, Bryan
    Saadedeen, Waleed
    Chauhan, Aditya
    di Nunzio, Sara
    Shah, Aashni
    Giacomelli, Luca
    Sacco, Rodolfo
    CELLS, 2021, 10 (12)
  • [34] Astaxanthin Prevents Alcoholic Fatty Liver Disease by Modulating Mouse Gut Microbiota
    Liu, Huilin
    Liu, Meihong
    Fu, Xueqi
    Zhang, Ziqi
    Zhu, Lingyu
    Zheng, Xin
    Liu, Jingsheng
    NUTRIENTS, 2018, 10 (09)
  • [35] Advancements in ferroptosis research and therapeutic strategies for alcoholic liver disease: a narrative review
    Bo, J. -Q.
    Guo, Z. -P.
    Han, Y. -H.
    Liu, L. -X.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (19) : 9296 - 9308
  • [36] Probiotics in treating with alcoholic liver disease and nonalcoholic fatty liver disease
    Liu, Lingchong
    Wang, Yu
    Zhang, Jing
    Wang, Chao
    Li, Youbao
    Dai, Weichang
    Piao, Chunhong
    Liu, Junmei
    Yu, Hansong
    Li, Xia
    Wang, Yuhua
    Liu, Jingsheng
    FOOD REVIEWS INTERNATIONAL, 2023, 39 (05) : 2723 - 2741
  • [37] Insights of mitochondrial involvement in alcoholic fatty liver disease
    Subramaiyam, Nithyananthan
    JOURNAL OF CELLULAR PHYSIOLOGY, 2023, 238 (10) : 2175 - 2190
  • [38] Protective Effects of Curcumin Against Alcoholic Fatty Liver
    Khoshakhlagh, Mahdieh
    Butler, Alexandra
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    CURRENT MEDICINAL CHEMISTRY, 2023, : 1702 - 1717
  • [39] Effect of Sildenafil on Non-Alcoholic Fatty Liver
    Alashry, Shereen Ezzelregal
    Gaballah, Mohammad A.
    Malek, Hala Abdel
    Abd Elsalam, Adel I.
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2015, 11 (07) : 814 - 820
  • [40] Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease
    Ashraf, N. U.
    Sheikh, T. A.
    FREE RADICAL RESEARCH, 2015, 49 (12) : 1405 - 1418